We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.99%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$52.3B
AUM Growth
-$3.99B
(-7.1%)
Cap. Flow
-$1.21B
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
1,740
New
31
Increased
388
Reduced
563
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$151M |
| 2 |
Johnson & Johnson
JNJ
|
+$111M |
| 3 |
Atlassian
TEAM
|
+$95.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$77.2M |
| 5 |
Capital One
COF
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$302M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$156M |
| 3 |
Apple
AAPL
|
+$132M |
| 4 |
Meta Platforms (Facebook)
META
|
+$95.1M |
| 5 |
NVIDIA
NVDA
|
+$94.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.6% |
| 2 | Financials | 14.62% |
| 3 | Healthcare | 13.57% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Avanos Medical
AVNS
| $342K | ﹤0.01% |
23,889
| – | – |
|
1627
Evolent Health
EVH
$421M
| $342K | ﹤0.01% |
36,089
| – | – |
|
1628
Viasat
VSAT
$10.1B
| $341K | ﹤0.01% |
32,766
| – | – |
|
1629
Novavax
NVAX
$1.21B
| $336K | ﹤0.01% |
52,400
| – | – |
|
1630
D-Wave Quantum Inc. Common Stock
QBTS
$6.53B
| $329K | ﹤0.01% |
+43,350
| New | +$291K |
|
1631
Fox Factory Holding Corp
FOXF
$801M
| $329K | ﹤0.01% |
14,113
| – | – |
|
1632
Applied Digital
APLD
$7.61B
| $329K | ﹤0.01% |
+58,550
| New | +$460K |
|
|
GRAL
1633
GRAIL Inc
GRAL
$2.76B
| $329K | ﹤0.01% |
12,877
| – | – |
|
1634
Vera Therapeutics
VERA
$2.39B
| $325K | ﹤0.01% |
13,550
| – | – |
|
1635
Ranpak Holdings
PACK
$550M
| $321K | ﹤0.01% |
59,194
| – | – |
|
1636
AMN Healthcare
AMN
$1.35B
| $321K | ﹤0.01% |
13,115
| – | – |
|
1637
Great Southern Bancorp
GSBC
$879M
| $319K | ﹤0.01% |
5,759
| – | – |
|
1638
B&G Foods
BGS
$297M
| $317K | ﹤0.01% |
+46,100
| New | +$308K |
|
1639
Simulations Plus
SLP
$371M
| $315K | ﹤0.01% |
12,861
| – | – |
|
1640
Legend Biotech
LEGN
$3.68B
| $307K | ﹤0.01% |
9,050
+1,200
| +15% | +$43K |
|
1641
Scholastic
SCHL
$766M
| $306K | ﹤0.01% |
16,218
| – | – |
|
1642
MaxLinear
MXL
$5.35B
| $305K | ﹤0.01% |
28,112
| – | – |
|
1643
Cohu
COHU
$2B
| $300K | ﹤0.01% |
20,401
| – | – |
|
1644
Rigetti Computing
RGTI
$4.83B
| $298K | ﹤0.01% |
+37,650
| New | +$418K |
|
1645
Monro
MNRO
$537M
| $295K | ﹤0.01% |
20,416
| – | – |
|
|
BOLD
1646
Boundless Bio
BOLD
$55.5M
| $283K | ﹤0.01% |
187,500
| – | – |
|
|
MRUS
1647
DELISTED
Merus
MRUS
| $282K | ﹤0.01% |
6,700
-107,300
| -94% | -$4.68M |
|
1648
Myriad Genetics
MYGN
$502M
| $280K | ﹤0.01% |
31,606
| – | – |
|
1649
XP
XP
$8.68B
| $279K | ﹤0.01% |
20,300
+9,600
| +90% | +$132K |
|
1650
Intellia Therapeutics
NTLA
$1.52B
| $278K | ﹤0.01% |
39,169
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Ensign Peak Advisors held 1,740 positions worth $52.3B, down 7.1% from $56.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.7%. Ensign Peak Advisors opened 31 new positions and exited 51, leaving the 1,740-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q1 2025 buy was iShares Russell 2000 ETF: 355,907 shares worth $71M.
- Ensign Peak Advisors added most to FTAI Aviation in Q1 2025, an estimated $151M increase.
- Ensign Peak Advisors's biggest Q1 2025 reduction was Thermo Fisher Scientific, cutting an estimated $156M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $302M.
- Ensign Peak Advisors's ten largest holdings make up 30% of its $52.3B portfolio in Q1 2025.
- Ensign Peak Advisors opened 31 new positions and closed 51 in Q1 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $52.3B.
Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.